ASX:COHMedical Equipment
How Cochlear’s FY26 Profit Downgrade At Cochlear (ASX:COH) Has Changed Its Investment Story
Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets.
This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions.
We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...